Extract from M&A Insights

The below story was originally featured in our daily M&A Insights Newsletter. Selected stories, including this one, are posted to our website with some weeks of delay.
Danish-company Symphogen rumored to go public
October 24, 2018

Danish Biotech company Symphogen will soon publish their intention to float document as long the current state of the stock market doesn’t worsens. Novo Holdings are the primarily owner and the IPO will be on a Danish Stock Exchange. The IPO is expected to value Symphogen as a DKK multi-billion company.

ⓘ This story was originally featured in our daily M&A Insights newsletter.
Our insights have been covered by: